web-based randomisation system trust Search Results


web-based service quickcalcs  (GraphPad Software Inc)
90
GraphPad Software Inc web-based service quickcalcs
Web Based Service Quickcalcs, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/web-based service quickcalcs/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
web-based service quickcalcs - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
web-based randomization system  (Cenduit GmbH)
90
Cenduit GmbH web-based randomization system
Web Based Randomization System, supplied by Cenduit GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/web-based randomization system/product/Cenduit GmbH
Average 90 stars, based on 1 article reviews
web-based randomization system - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
web-based academic survey tool  (Questback GmbH)
90
Questback GmbH web-based academic survey tool
Web Based Academic Survey Tool, supplied by Questback GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/web-based academic survey tool/product/Questback GmbH
Average 90 stars, based on 1 article reviews
web-based academic survey tool - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
secure web-based randomisation program  (MedSciNet UK Ltd)
90
MedSciNet UK Ltd secure web-based randomisation program
Maternal demographic and pregnancy characteristics at baseline and <t> randomisation </t>
Secure Web Based Randomisation Program, supplied by MedSciNet UK Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/secure web-based randomisation program/product/MedSciNet UK Ltd
Average 90 stars, based on 1 article reviews
secure web-based randomisation program - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
web-based survey tool  (DatStat Inc)
90
DatStat Inc web-based survey tool
Maternal demographic and pregnancy characteristics at baseline and <t> randomisation </t>
Web Based Survey Tool, supplied by DatStat Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/web-based survey tool/product/DatStat Inc
Average 90 stars, based on 1 article reviews
web-based survey tool - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
web-based randomisation procedure  (Institute for Clinical Pharmacodynamics)
90
Institute for Clinical Pharmacodynamics web-based randomisation procedure
Maternal demographic and pregnancy characteristics at baseline and <t> randomisation </t>
Web Based Randomisation Procedure, supplied by Institute for Clinical Pharmacodynamics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/web-based randomisation procedure/product/Institute for Clinical Pharmacodynamics
Average 90 stars, based on 1 article reviews
web-based randomisation procedure - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
interactive web-based response system bilcare ivrs solutions  (Bilcare Inc)
90
Bilcare Inc interactive web-based response system bilcare ivrs solutions
Maternal demographic and pregnancy characteristics at baseline and <t> randomisation </t>
Interactive Web Based Response System Bilcare Ivrs Solutions, supplied by Bilcare Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/interactive web-based response system bilcare ivrs solutions/product/Bilcare Inc
Average 90 stars, based on 1 article reviews
interactive web-based response system bilcare ivrs solutions - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
randomisation facility  (MedSciNet UK Ltd)
90
MedSciNet UK Ltd randomisation facility
Schedule of participant enrolment, interventions and assessments in the trial. PARCA-R Parent Report of Cognitive Abilities, Revised, SAE serious adverse event. 1 Screening to be conducted of all women suspected of being eligible for the study. 2 Delivery to be commenced within 48 hours of <t>randomisation</t> for women randomised to the planned delivery group. 3 Eligibility for study to be assessed from blood pressure recorded at the time the diagnosis of pre-eclampsia. 4 Blood systolic pressure reading within the 48 hours prior to randomisation to be recorded. 5 Highest systolic blood pressure recorded between randomisation and delivery to be recorded. 6 Highest systolic blood pressure recorded between delivery and discharge to be recorded. 7 Haematology and/or Biochemistry results that contributed to diagnosis of pre-eclampsia to be recorded. 8 The most recent Haematology and/or Biochemistry results prior to randomisation to be recorded. 9 Abnormal Haematology/ Biochemistry results from randomisation to discharge to be recorded at discharge. 10 Serious Adverse Events (SAEs) to be recorded from randomisation to post-natal discharge. Only unexpected SAEs to be reported. 11 Brief details of anti-hypertensive and medication for induction will be recorded; all other concomitant medication will only be recorded in the event that an unexpected Serious Adverse Event is reported. 12 EQ-5D-5L to be given to the participant to complete immediately after randomisation
Randomisation Facility, supplied by MedSciNet UK Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/randomisation facility/product/MedSciNet UK Ltd
Average 90 stars, based on 1 article reviews
randomisation facility - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
web-based system  (GraphPad Software Inc)
90
GraphPad Software Inc web-based system
Schedule of participant enrolment, interventions and assessments in the trial. PARCA-R Parent Report of Cognitive Abilities, Revised, SAE serious adverse event. 1 Screening to be conducted of all women suspected of being eligible for the study. 2 Delivery to be commenced within 48 hours of <t>randomisation</t> for women randomised to the planned delivery group. 3 Eligibility for study to be assessed from blood pressure recorded at the time the diagnosis of pre-eclampsia. 4 Blood systolic pressure reading within the 48 hours prior to randomisation to be recorded. 5 Highest systolic blood pressure recorded between randomisation and delivery to be recorded. 6 Highest systolic blood pressure recorded between delivery and discharge to be recorded. 7 Haematology and/or Biochemistry results that contributed to diagnosis of pre-eclampsia to be recorded. 8 The most recent Haematology and/or Biochemistry results prior to randomisation to be recorded. 9 Abnormal Haematology/ Biochemistry results from randomisation to discharge to be recorded at discharge. 10 Serious Adverse Events (SAEs) to be recorded from randomisation to post-natal discharge. Only unexpected SAEs to be reported. 11 Brief details of anti-hypertensive and medication for induction will be recorded; all other concomitant medication will only be recorded in the event that an unexpected Serious Adverse Event is reported. 12 EQ-5D-5L to be given to the participant to complete immediately after randomisation
Web Based System, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/web-based system/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
web-based system - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
web-based intervention philips directlife  (Philips Healthcare)
90
Philips Healthcare web-based intervention philips directlife
Schedule of participant enrolment, interventions and assessments in the trial. PARCA-R Parent Report of Cognitive Abilities, Revised, SAE serious adverse event. 1 Screening to be conducted of all women suspected of being eligible for the study. 2 Delivery to be commenced within 48 hours of <t>randomisation</t> for women randomised to the planned delivery group. 3 Eligibility for study to be assessed from blood pressure recorded at the time the diagnosis of pre-eclampsia. 4 Blood systolic pressure reading within the 48 hours prior to randomisation to be recorded. 5 Highest systolic blood pressure recorded between randomisation and delivery to be recorded. 6 Highest systolic blood pressure recorded between delivery and discharge to be recorded. 7 Haematology and/or Biochemistry results that contributed to diagnosis of pre-eclampsia to be recorded. 8 The most recent Haematology and/or Biochemistry results prior to randomisation to be recorded. 9 Abnormal Haematology/ Biochemistry results from randomisation to discharge to be recorded at discharge. 10 Serious Adverse Events (SAEs) to be recorded from randomisation to post-natal discharge. Only unexpected SAEs to be reported. 11 Brief details of anti-hypertensive and medication for induction will be recorded; all other concomitant medication will only be recorded in the event that an unexpected Serious Adverse Event is reported. 12 EQ-5D-5L to be given to the participant to complete immediately after randomisation
Web Based Intervention Philips Directlife, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/web-based intervention philips directlife/product/Philips Healthcare
Average 90 stars, based on 1 article reviews
web-based intervention philips directlife - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
web-based randomization and drug supply management system webez  (Almac Inc)
90
Almac Inc web-based randomization and drug supply management system webez
Schedule of participant enrolment, interventions and assessments in the trial. PARCA-R Parent Report of Cognitive Abilities, Revised, SAE serious adverse event. 1 Screening to be conducted of all women suspected of being eligible for the study. 2 Delivery to be commenced within 48 hours of <t>randomisation</t> for women randomised to the planned delivery group. 3 Eligibility for study to be assessed from blood pressure recorded at the time the diagnosis of pre-eclampsia. 4 Blood systolic pressure reading within the 48 hours prior to randomisation to be recorded. 5 Highest systolic blood pressure recorded between randomisation and delivery to be recorded. 6 Highest systolic blood pressure recorded between delivery and discharge to be recorded. 7 Haematology and/or Biochemistry results that contributed to diagnosis of pre-eclampsia to be recorded. 8 The most recent Haematology and/or Biochemistry results prior to randomisation to be recorded. 9 Abnormal Haematology/ Biochemistry results from randomisation to discharge to be recorded at discharge. 10 Serious Adverse Events (SAEs) to be recorded from randomisation to post-natal discharge. Only unexpected SAEs to be reported. 11 Brief details of anti-hypertensive and medication for induction will be recorded; all other concomitant medication will only be recorded in the event that an unexpected Serious Adverse Event is reported. 12 EQ-5D-5L to be given to the participant to complete immediately after randomisation
Web Based Randomization And Drug Supply Management System Webez, supplied by Almac Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/web-based randomization and drug supply management system webez/product/Almac Inc
Average 90 stars, based on 1 article reviews
web-based randomization and drug supply management system webez - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
web-based response system  (Theradex Systems Inc)
90
Theradex Systems Inc web-based response system
Schedule of participant enrolment, interventions and assessments in the trial. PARCA-R Parent Report of Cognitive Abilities, Revised, SAE serious adverse event. 1 Screening to be conducted of all women suspected of being eligible for the study. 2 Delivery to be commenced within 48 hours of <t>randomisation</t> for women randomised to the planned delivery group. 3 Eligibility for study to be assessed from blood pressure recorded at the time the diagnosis of pre-eclampsia. 4 Blood systolic pressure reading within the 48 hours prior to randomisation to be recorded. 5 Highest systolic blood pressure recorded between randomisation and delivery to be recorded. 6 Highest systolic blood pressure recorded between delivery and discharge to be recorded. 7 Haematology and/or Biochemistry results that contributed to diagnosis of pre-eclampsia to be recorded. 8 The most recent Haematology and/or Biochemistry results prior to randomisation to be recorded. 9 Abnormal Haematology/ Biochemistry results from randomisation to discharge to be recorded at discharge. 10 Serious Adverse Events (SAEs) to be recorded from randomisation to post-natal discharge. Only unexpected SAEs to be reported. 11 Brief details of anti-hypertensive and medication for induction will be recorded; all other concomitant medication will only be recorded in the event that an unexpected Serious Adverse Event is reported. 12 EQ-5D-5L to be given to the participant to complete immediately after randomisation
Web Based Response System, supplied by Theradex Systems Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/web-based response system/product/Theradex Systems Inc
Average 90 stars, based on 1 article reviews
web-based response system - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Maternal demographic and pregnancy characteristics at baseline and randomisation

Journal: Lancet (London, England)

Article Title: Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial

doi: 10.1016/S0140-6736(19)31963-4

Figure Lengend Snippet: Maternal demographic and pregnancy characteristics at baseline and randomisation

Article Snippet: Randomisation was managed via a secure web-based randomisation program provided by MedSciNet.

Techniques:

Schedule of participant enrolment, interventions and assessments in the trial. PARCA-R Parent Report of Cognitive Abilities, Revised, SAE serious adverse event. 1 Screening to be conducted of all women suspected of being eligible for the study. 2 Delivery to be commenced within 48 hours of randomisation for women randomised to the planned delivery group. 3 Eligibility for study to be assessed from blood pressure recorded at the time the diagnosis of pre-eclampsia. 4 Blood systolic pressure reading within the 48 hours prior to randomisation to be recorded. 5 Highest systolic blood pressure recorded between randomisation and delivery to be recorded. 6 Highest systolic blood pressure recorded between delivery and discharge to be recorded. 7 Haematology and/or Biochemistry results that contributed to diagnosis of pre-eclampsia to be recorded. 8 The most recent Haematology and/or Biochemistry results prior to randomisation to be recorded. 9 Abnormal Haematology/ Biochemistry results from randomisation to discharge to be recorded at discharge. 10 Serious Adverse Events (SAEs) to be recorded from randomisation to post-natal discharge. Only unexpected SAEs to be reported. 11 Brief details of anti-hypertensive and medication for induction will be recorded; all other concomitant medication will only be recorded in the event that an unexpected Serious Adverse Event is reported. 12 EQ-5D-5L to be given to the participant to complete immediately after randomisation

Journal: Trials

Article Title: Planned delivery or expectant management for late preterm pre-eclampsia: study protocol for a randomised controlled trial (PHOENIX trial)

doi: 10.1186/s13063-018-3150-1

Figure Lengend Snippet: Schedule of participant enrolment, interventions and assessments in the trial. PARCA-R Parent Report of Cognitive Abilities, Revised, SAE serious adverse event. 1 Screening to be conducted of all women suspected of being eligible for the study. 2 Delivery to be commenced within 48 hours of randomisation for women randomised to the planned delivery group. 3 Eligibility for study to be assessed from blood pressure recorded at the time the diagnosis of pre-eclampsia. 4 Blood systolic pressure reading within the 48 hours prior to randomisation to be recorded. 5 Highest systolic blood pressure recorded between randomisation and delivery to be recorded. 6 Highest systolic blood pressure recorded between delivery and discharge to be recorded. 7 Haematology and/or Biochemistry results that contributed to diagnosis of pre-eclampsia to be recorded. 8 The most recent Haematology and/or Biochemistry results prior to randomisation to be recorded. 9 Abnormal Haematology/ Biochemistry results from randomisation to discharge to be recorded at discharge. 10 Serious Adverse Events (SAEs) to be recorded from randomisation to post-natal discharge. Only unexpected SAEs to be reported. 11 Brief details of anti-hypertensive and medication for induction will be recorded; all other concomitant medication will only be recorded in the event that an unexpected Serious Adverse Event is reported. 12 EQ-5D-5L to be given to the participant to complete immediately after randomisation

Article Snippet: Randomisation will be managed via a secure web-based randomisation facility hosted by MedSciNet with a telephone back-up available at all times.

Techniques: Biomarker Discovery